hVIVO plc Notice of Preliminary Results (2370S)
08 March 2019 - 6:01PM
UK Regulatory
TIDMHVO
RNS Number : 2370S
hVIVO plc
08 March 2019
hVIVO plc
("hVIVO" or the "Company")
Notice of Preliminary Results
London, UK 8 March 2019: hVIVO plc (AIM: HVO), an industry
leading clinical development services business pioneering human
disease models based upon viral and allergen challenge, will
announce its preliminary financial results for the twelve months
ended 31 December 2018 on Thursday 11 April 2019.
A presentation and webcast for analysts will be held at 9.00am
BST at the offices of FTI Consulting, 200 Aldersgate, Aldersgate
Street, London, EC1A 4HD, with registration and coffee from 8.45am.
A webcast recording of the event will be available on the Company's
website.
For further information please contact:
hVIVO plc
Trevor Phillips (Executive Chairman) +44 207 756 1300
Shelley Fraser (Finance Director & Company Secretary)
Fleur Wood (EVP, Investor Relations & Communications)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
FTI Consulting
Simon Conway / Victoria Foster Mitchell +44 203 727 1000
Notes to Editors:
hVIVO plc ("hVIVO") is pioneering a human-based clinical trial
platform to accelerate drug and vaccine development in respiratory
and infectious diseases. Leveraging human disease models in flu,
RSV, HRV and respiratory indications, the hVIVO platform captures
disease in motion, illuminating the entire disease life cycle from
healthy to sick and back to health. Based in the UK, market leader
hVIVO has conducted more than 50 clinical studies and inoculated
over 2500 volunteers.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORUGUQCWUPBGMM
(END) Dow Jones Newswires
March 08, 2019 02:01 ET (07:01 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Apr 2024 to May 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From May 2023 to May 2024